Disease: Hematologic Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0376545
Disease: Hematologic Neoplasms
Hematologic Neoplasms 		0.050 GeneticVariation group BEFREE Preferentially expressed antigen of melanoma (<i>PRAME</i>), a tumor-associated antigen, is overexpressed in a variety of hematologic malignancies with a great variation in expression. 28454473 2017
CUI: C0376545
Disease: Hematologic Neoplasms
Hematologic Neoplasms 		0.050 Biomarker group BEFREE These PRAME-directed CTLs did not affect normal hematopoietic progenitors, indicating that this approach may be of value for immunotherapy of PRAME(+) hematologic malignancies. 21278353 2011
CUI: C0376545
Disease: Hematologic Neoplasms
Hematologic Neoplasms 		0.050 AlteredExpression group BEFREE The cancer testis antigen (CTA) preferentially expressed antigen of melanoma (PRAME) is overexpressed in many hematologic malignancies, including chronic myeloid leukemia (CML). 18591381 2008
CUI: C0376545
Disease: Hematologic Neoplasms
Hematologic Neoplasms 		0.050 AlteredExpression group BEFREE PRAME is expressed at low levels in normal testes and highly in solid tumor cells and hematological malignancies. 16860864 2007
CUI: C0376545
Disease: Hematologic Neoplasms
Hematologic Neoplasms 		0.050 AlteredExpression group BEFREE We tested by RT-PCR the expression of PRAME on more than 250 bone marrow or blood samples from patients with a haematological malignancy. 9753074 1998